Your email has been successfully added to our mailing list.

×
0 0 0.0064935064935065 0.0584415584415585 0.136363636363636 0.064935064935065 0.0390259740259741 0.0454545454545455
Analyst impact report

Immune Design Corp (NASDAQ: IMDZ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $11.00 price target on the stock.

IMMUNE DESIGN CORP COMMON STOCK (IMDZ) 
Last immune design corp common stock earnings: 11/6 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.immunedesign.com/investor-relations
Company Research Source: MarketBeat
Impact Snapshot
Event Time:
IMDZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for IMDZ alerts
Opt-in for
IMDZ alerts

from News Quantified
Opt-in for
IMDZ alerts

from News Quantified